Heart failure in India: An area of darkness

National Medical Journal of India

Volumn 24, Issue 1, 2011, Pages 53-

  Pais, Prem ^a   Xavier, Denis ^b  

^a Department of Medicine ^*  (India)

^b ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

NESIRITIDE;

ARTICLE; DIABETES MELLITUS; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; HYPERTENSION; INDIA; ISCHEMIC HEART DISEASE; PREVALENCE; PUBLIC HEALTH PROBLEM; RESTRICTIVE CARDIOMYOPATHY; RHEUMATIC HEART DISEASE; SOCIOECONOMICS; VALVULAR HEART DISEASE;

HEART FAILURE; HUMANS; INCIDENCE; INDIA; PREVALENCE;

EID: 79955563466     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Huffman MD, Prabhakaran D. Heart failure: Epidemiology and prevention in India. Natl Med J India 2010;23:283-8.
2. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000;83:596-602.
3. Sanderson JE. Heart failure-A growing epidemic in Asia. Hong Kong Med J 2004; 10:76.
4. Sanderson JE, Tse TF. Heart failure: A global disease requiring a global response. Heart 2003;89:585-6.
5. Krum H, Abraham WT. Heart failure. Lancet 2009;373:941-55.
6. Yip GW, Wang M, Wang T, Chan S, Fung JW, Yeung L, et al. The Hong Kong diastolic heart failure study: A randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction. Heart 2008;94:573-80.
7. Dhandapany PS, Sadayappan S, Xue Y, Powell GT, Rani DS, Nallari P, et al. A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia. Nat Genet 2009;41:187-91.